Suppr超能文献

C3d 抗原在肾脏和皮肤组织病理学中的诊断意义——最新技术和实际应用。

The Diagnostic Significance of C3d Antigen in Kidney and Skin Histopathology - The Current State-Of-The-Art and Practical Examples.

机构信息

DB Biotech, a.s., Košice, Slovak Republic.

出版信息

Physiol Res. 2023 Oct 27;72(S3):S225-S232. doi: 10.33549/physiolres.935175.

Abstract

The aim of this narrative review is to summarize recent knowledge about the diagnostic significance of immunobiological detection of C3d with a focus on renal and skin tissue biopsies. We completed the present narrative review with our own experiences with preparation and practical use of monoclonal C3d antibodies at a small national level.

摘要

本综述的目的是总结最近关于免疫生物学检测 C3d 的诊断意义的知识,重点是肾和皮肤组织活检。我们在小范围内完成了本综述,介绍了我们自己在准备和实际使用单克隆 C3d 抗体方面的经验。

相似文献

2
Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies.
Transplantation. 2005 May 27;79(10):1435-40. doi: 10.1097/01.tp.0000158420.26623.0f.
3
Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.
J Am Soc Nephrol. 2015 Feb;26(2):457-67. doi: 10.1681/ASN.2013101144. Epub 2014 Aug 14.
4
Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.
PLoS One. 2018 Nov 14;13(11):e0207434. doi: 10.1371/journal.pone.0207434. eCollection 2018.
5
Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.
J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.
6
Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies.
Pediatr Nephrol. 2018 Jan;33(1):167-174. doi: 10.1007/s00467-017-3772-7. Epub 2017 Sep 16.
9
Clinical Significance of C3d Assay in Kidney Transplant Recipients With Donor-Specific Anti-Human Leukocyte Antigen Antibodies.
Transplant Proc. 2022 Mar;54(2):341-345. doi: 10.1016/j.transproceed.2021.10.020. Epub 2022 Jan 13.

引用本文的文献

1
Therapeutic strategies targeting complement in myasthenia gravis patients.
J Neurol. 2025 Jul 2;272(8):489. doi: 10.1007/s00415-025-13225-7.

本文引用的文献

1
What the rheumatologist needs to know about skin biopsy.
Best Pract Res Clin Rheumatol. 2023 Mar;37(1):101838. doi: 10.1016/j.berh.2023.101838. Epub 2023 May 31.
2
Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
Front Immunol. 2023 Apr 25;14:1159351. doi: 10.3389/fimmu.2023.1159351. eCollection 2023.
3
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Am J Clin Dermatol. 2023 Jul;24(4):521-540. doi: 10.1007/s40257-023-00774-8. Epub 2023 May 4.
4
C3d immunohistochemistry in the diagnosis of bullous pemphigoid: A comparative diagnostic test accuracy and cost analysis study.
J Am Acad Dermatol. 2023 Aug;89(2):413-415. doi: 10.1016/j.jaad.2023.04.016. Epub 2023 Apr 19.
5
Analyses of the clinical and immunological characteristics of patients with lupus erythematosus.
Indian J Dermatol. 2022 Mar-Apr;67(2):205. doi: 10.4103/ijd.ijd_942_20.
7
Novel Biomarkers in Kidney Transplantation.
Semin Nephrol. 2022 Jan;42(1):2-13. doi: 10.1016/j.semnephrol.2022.01.007.
8
Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney.
Front Immunol. 2022 Apr 13;13:845301. doi: 10.3389/fimmu.2022.845301. eCollection 2022.
9
Histopathologic Features of Antibody Mediated Rejection: The Banff Classification and Beyond.
Front Immunol. 2021 Sep 27;12:718122. doi: 10.3389/fimmu.2021.718122. eCollection 2021.
10
Complement Activation in Kidneys of Patients With COVID-19.
Front Immunol. 2021 Jan 29;11:594849. doi: 10.3389/fimmu.2020.594849. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验